{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:08:35Z","timestamp":1779466115072,"version":"3.53.1"},"reference-count":42,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":21,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2025-PUMCH-C-026"],"award-info":[{"award-number":["2025-PUMCH-C-026"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,4,13]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:p>Ocular involvement in antiphospholipid syndrome typically manifests as retinal artery or vein occlusions. Isolated progressive retinal microvascular impairment as associated with antiphospholipid antibodies (aPL) is rare and poorly characterised.<\/jats:p>\n                  <jats:p>This study is a retrospective case report and literature review. A 35-year-old male presented with bilateral progressive retinal microvascular impairment as the sole clinical manifestation, characterised by concentric capillary dropout beginning in the far periphery and extending towards the juxtafoveal region, accompanied by progressive enlargement of the foveal avascular zone. Laboratory tests confirmed persistently elevated anti-beta-2-glycoprotein-1 IgM. Ultra-widefield fluorescein angiography and optical coherence tomography angiography comprehensively documented the microvascular impairment. Despite sequential treatment with pan-retinal photocoagulation, antiplatelet, anticoagulant and immunosuppressive therapies, microvascular deterioration progressed. Scattered recanalisation of occluded microvasculature was observed following the introduction of sirolimus.<\/jats:p>\n                  <jats:p>This case provides longitudinal in vivo evidence for the involvement of aPL in the pathogenesis of progressive retinal microcirculatory compromise. The advancement of ocular imaging techniques, especially ultra-widefield angiography and optical coherence tomography angiography, is critical for the recognition and characterisation of this microvascular phenotype, which may expand the clinical spectrum of aPL-related microvascular diseases.<\/jats:p>","DOI":"10.1136\/lupus-2026-002023","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:55:13Z","timestamp":1779465313000},"page":"e002023","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Antiphospholipid antibody associated retinal microvascular impairment: a case report and literature review"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0096-2050","authenticated-orcid":false,"given":"Erqian","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-5651-7404","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China"},{"name":"Ministry of Science & Technology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Dongcheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1289-6460","authenticated-orcid":false,"given":"Lu","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-5058","authenticated-orcid":false,"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiuliang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Peking Union Medical College Hospital, Beijing, China"},{"name":"Ministry of Science & Technology, National Clinical Research Center for Dermatologic and Immunologic Diseases, Dongcheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"2026052208550530000_13.1.e002023.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1705454"},{"key":"2026052208550530000_13.1.e002023.2","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1002\/art.42624","article-title":"The 2023 ACR\/EULAR Antiphospholipid Syndrome Classification Criteria","volume":"75","author":"Barbhaiya","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"2026052208550530000_13.1.e002023.3","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.182857"},{"key":"2026052208550530000_13.1.e002023.4","first-page":"178","article-title":"Characteristics and risk factors of retinal vasculopathy in antiphospholipid syndrome","volume":"31","author":"Xie","year":"2022","journal-title":"Lupus (Los Angel)"},{"key":"2026052208550530000_13.1.e002023.5","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1097\/IAE.0000000000003185","article-title":"CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME AND POSTERIOR OCULAR INVOLVEMENT: Case Series of 11 Patients and Literature Review","volume":"41","author":"Morel","year":"2021","journal-title":"Retina"},{"key":"2026052208550530000_13.1.e002023.6","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9394(86)90206-0","article-title":"Central retinal artery occlusion in Sneddon\u2019s disease associated with antiphospholipid antibodies","volume":"102","author":"Jonas","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"2026052208550530000_13.1.e002023.7","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-198707040-00002"},{"key":"2026052208550530000_13.1.e002023.8","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/S0161-6420(88)33139-8","article-title":"Visual Symptoms Associated with the Presence of a Lupus Anticoagulant","volume":"95","author":"Levine","year":"1988","journal-title":"Ophthalmology"},{"key":"2026052208550530000_13.1.e002023.9","unstructured":"AS D , SG J . Primary antiphospholipid syndrome. J Rheumatol 1989;16. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/2746588\/"},{"key":"2026052208550530000_13.1.e002023.10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0161-6420(89)32825-9","article-title":"Vaso-occlusive retinopathy associated with antiphospholipid antibodies (lupus anticoagulant retinopathy)","volume":"96","author":"Kleiner","year":"1989","journal-title":"Ophthalmology"},{"key":"2026052208550530000_13.1.e002023.11","unstructured":"Central retinal-artery occlusion in a patient with circulating lupus anticoagulant - pubmed. Available: https:\/\/pubmed.ncbi.nlm.nih.gov\/2505658\/ [Accessed 1 Feb 2026]."},{"key":"2026052208550530000_13.1.e002023.12","doi-asserted-by":"crossref","DOI":"10.1136\/ard.49.3.203","article-title":"Occlusive ocular vascular disease and antiphospholipid antibodies","volume":"49","author":"Tolosa-Vilella","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"2026052208550530000_13.1.e002023.13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/eye.1991.10","article-title":"Vaso-occlusive retinopathy in the primary anti-phospholipid antibody syndrome","volume":"5 (Pt 1)","author":"Acheson","year":"1991","journal-title":"Eye (Lond)"},{"key":"2026052208550530000_13.1.e002023.14","doi-asserted-by":"publisher","DOI":"10.1007\/BF00319714"},{"key":"2026052208550530000_13.1.e002023.15","first-page":"772","article-title":"Retinal vasculitis and antiphospholipid antibodies","volume":"91","author":"Zierhut","year":"1994","journal-title":"Ophthalmologe"},{"key":"2026052208550530000_13.1.e002023.16","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0161-6420(95)31028-7","article-title":"Ocular vaso-occlusive disease in primary antiphospholipid syndrome","volume":"102","author":"Casta\u00f1\u00f3n","year":"1995","journal-title":"Ophthalmology"},{"key":"2026052208550530000_13.1.e002023.17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S0002-9394(14)71142-0","article-title":"Primary antiphospholipid antibody syndrome and retinal occlusive vasculopathy","volume":"123","author":"Wiechens","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"2026052208550530000_13.1.e002023.18","doi-asserted-by":"publisher","DOI":"10.1097\/00006982-200212000-00016"},{"key":"2026052208550530000_13.1.e002023.19","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(02)02078-0"},{"key":"2026052208550530000_13.1.e002023.20","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F"},{"key":"2026052208550530000_13.1.e002023.21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01753.x"},{"key":"2026052208550530000_13.1.e002023.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.05.004"},{"key":"2026052208550530000_13.1.e002023.23","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001332","article-title":"Dancing with disorder: chorea - an unusual and neglected manifestation of antiphospholipid syndrome","volume":"11","author":"Hu","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026052208550530000_13.1.e002023.24","doi-asserted-by":"crossref","unstructured":"Ambati A , Ma F , Kmetova K , et al . Molecular Stratification of Antiphospholipid Syndrome Through Integrative Analysis of the Whole-Blood RNA Transcriptome. Arthritis Rheumatol 2025;15. doi:10.1002\/art.70021","DOI":"10.1002\/art.70021"},{"key":"2026052208550530000_13.1.e002023.25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26062750","article-title":"Activation of the Mammalian Target of Rapamycin Pathway in Endothelial Cells in Antiphospholipid Antibody-Positive Patients with Leg Ulcers","volume":"26","author":"Kov\u00e1cs","year":"2025","journal-title":"Int J Mol Sci"},{"key":"2026052208550530000_13.1.e002023.26","doi-asserted-by":"crossref","first-page":"150909","DOI":"10.1016\/j.tmrv.2025.150909","article-title":"Analytical Review: Neutrophil Extracellular Traps and Antiphospholipid syndrome","volume":"40","author":"Butt","year":"2026","journal-title":"Transfus Med Rev"},{"key":"2026052208550530000_13.1.e002023.27","doi-asserted-by":"crossref","unstructured":"Ducker CB , Preece MV , Pericleous C , et al . Revisiting antiphospholipid syndrome: A thrombo-inflammatory disorder beyond clotting. Blood Rev 2026;101364. doi:10.1016\/j.blre.2026.101364","DOI":"10.1016\/j.blre.2026.101364"},{"key":"2026052208550530000_13.1.e002023.28","first-page":"313","article-title":"Antiphospholipid antibodies and retinal vascular disease","volume":"5","author":"Dunn","year":"1996","journal-title":"Lupus (Los Angel)"},{"key":"2026052208550530000_13.1.e002023.29","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(00)00300-2"},{"key":"2026052208550530000_13.1.e002023.30","doi-asserted-by":"publisher","DOI":"10.1080\/09273940902989340"},{"key":"2026052208550530000_13.1.e002023.31","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1016\/j.jcjo.2012.07.010","article-title":"Bilateral occlusive retinal vasculitis in a patient with primary antiphospholipid antibody syndrome","volume":"47","author":"Turaka","year":"2012","journal-title":"Can J Ophthalmol"},{"key":"2026052208550530000_13.1.e002023.32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3928\/23258160-20170130-13","article-title":"Optical Coherence Tomography Angiography of Paracentral Acute Middle Maculopathy Associated With Primary Antiphospholipid Syndrome","volume":"48","author":"Trese","year":"2017","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2026052208550530000_13.1.e002023.33","first-page":"1800","article-title":"Ocular findings in asymptomatic patients with primary antiphospholipid syndrome","volume":"31","author":"Neto","year":"2022","journal-title":"Lupus (Los Angel)"},{"key":"2026052208550530000_13.1.e002023.34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/art.33469","article-title":"Clinical images: Peripheral retinal neovascularization in the antiphospholipid antibody syndrome","volume":"64","author":"Lyles","year":"2012","journal-title":"Arthritis & Rheumatism"},{"key":"2026052208550530000_13.1.e002023.35","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1097\/IAE.0000000000002593","article-title":"Ultra-widefield Imaging of Vasoocclusive Retinopathy Secondary to Antiphospholipid Syndrome","volume":"39","author":"Cicinelli","year":"2019","journal-title":"Retina"},{"key":"2026052208550530000_13.1.e002023.36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S0021-5155(99)00105-7","article-title":"White thread-like retinal arterioles associated with antiphospholipid antibody syndrome","volume":"43","author":"Suzuki","year":"1999","journal-title":"Jpn J Ophthalmol"},{"key":"2026052208550530000_13.1.e002023.37","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90450-5"},{"key":"2026052208550530000_13.1.e002023.38","first-page":"79","article-title":"Early subclinical macular disease in asymptomatic patients with primary antiphospholipid syndrome: A quantitative multimodal retinal evaluation","volume":"34","author":"Zacharias","year":"2025","journal-title":"Lupus (Los Angel)"},{"key":"2026052208550530000_13.1.e002023.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101292"},{"key":"2026052208550530000_13.1.e002023.40","doi-asserted-by":"publisher","DOI":"10.1001\/archopthalmol.2011.1363"},{"key":"2026052208550530000_13.1.e002023.41","doi-asserted-by":"crossref","DOI":"10.1186\/s12348-016-0089-9","article-title":"Bilateral frosted branch angiitis as the presenting sign of antiphospholipid antibody syndrome","volume":"6","author":"Wood","year":"2016","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"2026052208550530000_13.1.e002023.42","doi-asserted-by":"crossref","DOI":"10.1186\/s12886-023-02935-z","article-title":"Purtscher-like retinopathy following coronary artery bypass grafting in an antiphospholipid syndrome patient: a case report","volume":"23","author":"Ameen Ismail","year":"2023","journal-title":"BMC Ophthalmol"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-002023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:55:17Z","timestamp":1779465317000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-002023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,5,22]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/lupus-2026-002023"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-002023","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}